| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |